Pet medicine report lookup / Afoxolaner / Cats

What has been reported to the FDA for Afoxolaner in cats?

Short answer: The FDA has received 86 adverse event reports for cats that name Afoxolaner. The FDA lists 1 approved animal drug application containing Afoxolaner for cats, the earliest approved in 2023. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Afoxolanerin cats
86reports to the FDA

The FDA has received 86 adverse event reports for cats that name Afoxolaner.

  1. 86 reports name Afoxolaner in cats, which is 0.1% of all 151,164 cat reports. A report counts under every active ingredient it names.
  2. With fewer than 100 reports, percentages are not shown. The counts are below.
  3. The clinical signs reported most are vomiting, administration error and lethargy.
  4. The FDA lists 1 approved animal drug application containing Afoxolaner for cats, the earliest approved in 2023.
  5. None of this is a rate. The FDA data does not record how many cats were given Afoxolaner, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll cat reports
Marked seriousthe FDA record flags the report as serious26too few reports to show a share27%
Death or euthanasiathe outcome recorded in the report, with no finding of cause4too few reports to show a share9.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event10too few reports to show a share19%
Seizurea seizure or convulsion is among the clinical signs2too few reports to show a share2.6%
Not used per labelthe report says the product was not used the way its label directs72too few reports to show a share33%

Where on the body do the reported signs sit?

36%12%7.6%6.8%4.2%

Not on the body: Whole body 14% How it was given 10% Did not work 6.8%

  1. Stomach and gut36%vomiting, not eating, inappetence, diarrhoea and 4 more
  2. Whole body14%lethargy, lethargy, death
  3. Behaviour12%hyperactivity, behavioural disorder, vocalisation
  4. How it was given10%administration error, accidental exposure
  5. Blood and organ tests7.6%elevated betahydroxybutyrate (bhba), hyperglycaemia, other abnormal test result
  6. Skin and coat6.8%itching, pruritus
  7. Did not work6.8%lack of efficacy (ectoparasite) - flea, lack of efficacy
  8. Heart and breathing4.2%panting
  9. Brain and nerves3.4%ataxia

Each figure is a share of sign mentions among the 25 signs reported most for Afoxolaner in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. Vomiting15
  2. Administration error8
  3. Lethargy8
  4. Hyperactivity6
  5. Not eating6
  6. Inappetence5
  7. Itching5
  8. Lack of efficacy (ectoparasite) - flea5

Reports received per year

1402014: 3 reports2015: 3 reports2016: 8 reports2017: 10 reports2018: 4 reports2019: 7 reports2020: 7 reports2021: 1 reports2022: 2 reports2023: 13 reports2024: 6 reports2025: 14 reports2026: 8 reports2014201620182020202220242026first approved for cats
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 14 reports (2025). The earliest FDA approval for cats was in 2023.

Is it approved for cats?

DogsFDA-approved product listed
CatsFDA-approved product listed
Other animalsnone found
FDA-approved for cats

The FDA lists 1 approved animal drug application containing Afoxolaner for cats, the earliest approved in 2023.

ProductFormApproved forFirst approvedFDA application
Nexgard ComboBoehringer lngelheim Animal Health USA, Inc.Topical Solution RXCat2023141-570

What can you do next?

What it cost in our price study$92 to $128 at a vet officeNexGard (afoxolaner), chewable, medium dog. The same study recorded $72 at Chewy and $78 at PetMeds. Prices collected April to May 2026; quantity and method are in the study.
Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. See Afoxolaner in dogs (65,969 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save